186 related articles for article (PubMed ID: 6552837)
41. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage.
Meloni FJ; Gustafson EJ; Schmaier AH
Blood; 1992 Mar; 79(5):1233-44. PubMed ID: 1536948
[TBL] [Abstract][Full Text] [Related]
42. Radioimmunoassay of human high molecular weight kininogen in normal and deficient plasmas.
Proud D; Pierce JV; Pisano JJ
J Lab Clin Med; 1980 Apr; 95(4):563-74. PubMed ID: 6153694
[TBL] [Abstract][Full Text] [Related]
43. Immunochemical studies of human kininogen.
Kerbiriou DM; Griffin JH; Larrieu MJ
Adv Exp Med Biol; 1983; 156():233-40. PubMed ID: 6858754
[TBL] [Abstract][Full Text] [Related]
44. Purification of high molecular weight kininogen and the role of this agent in blood coagulation.
Saito H
J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664
[TBL] [Abstract][Full Text] [Related]
45. [Identification of kinins releasing by pig pancreatic kallikrein from rabbit low molecular weight kininogen].
Paskhina TS; Makevnina LG; Egorova TP; Levina GO
Biokhimiia; 1977 Jun; 42(6):1144-7. PubMed ID: 889975
[TBL] [Abstract][Full Text] [Related]
46. Rodent kinin-forming enzyme systems--I. Purification and characterization of plasma kininogen.
Bedi GS; Balwierczak J; Back N
Biochem Pharmacol; 1983 Jul; 32(13):2061-9. PubMed ID: 6870934
[TBL] [Abstract][Full Text] [Related]
47. [Single-chain, low molecular weight kininogen in the blood plasma of rabbits: isolation and fragmentation by porcine pancreatic kallikrein].
Levina GO; Makevnina LG; Sherstiuk SF; Paskhina TS
Biokhimiia; 1985 Feb; 50(2):325-36. PubMed ID: 3845817
[TBL] [Abstract][Full Text] [Related]
48. Cysteine proteinase inhibitor in the ascitic fluid of sarcoma 180 tumor-bearing mice is a low molecular weight kininogen. Partial NH2- and COOH-terminal sequences and susceptibility to various glandular kallikreins.
Sueyoshi T; Uwani M; Itoh N; Okamoto H; Muta T; Tokunaga F; Takada K; Iwanaga S
J Biol Chem; 1990 Jun; 265(17):10030-5. PubMed ID: 2351646
[TBL] [Abstract][Full Text] [Related]
49. Studies on the kinin formation by bovine spleen acid kininogenases.
Yamafuji K; Watanabe M
Adv Exp Med Biol; 1983; 156():409-18. PubMed ID: 6552847
[TBL] [Abstract][Full Text] [Related]
50. Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain.
Herwald H; Jahnen-Dechent W; Alla SA; Hock J; Bouma BN; Müller-Esterl W
J Biol Chem; 1993 Jul; 268(19):14527-35. PubMed ID: 7686159
[TBL] [Abstract][Full Text] [Related]
51. Functionally active high molecular weight-kininogen was found in the liver, but not in the plasma of brown Norway Katholiek rat.
Hayashi I; Maruhashi J; Oh-ishi S
Thromb Res; 1989 Oct; 56(2):179-89. PubMed ID: 2617467
[TBL] [Abstract][Full Text] [Related]
52. Amino acid sequence of the light chain of human low molecular mass kininogen.
Lottspeich F; Kellermann J; Henschen A; Rauth G; Müller-Esterl W
Adv Exp Med Biol; 1986; 198 Pt A():91-5. PubMed ID: 3812098
[TBL] [Abstract][Full Text] [Related]
53. Characterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen.
Thompson RE; Mandle R; Kaplan AP
J Exp Med; 1978 Feb; 147(2):488-99. PubMed ID: 75240
[TBL] [Abstract][Full Text] [Related]
54. Purification and characterization of alpha 1-thiol proteinase inhibitor and its identity with kinin- and fragment 1.2-free high molecular weight kininogen.
Ohkubo I; Namikawa C; Higashiyama S; Sasaki M; Minowa O; Mizuno Y; Shiokawa H
Int J Biochem; 1988; 20(3):243-58. PubMed ID: 3356290
[TBL] [Abstract][Full Text] [Related]
55. Contact activation of plasma: structure-activity relationships of human high molecular weight kininogen.
Kerbiriou D; Griffin JH
Adv Exp Med Biol; 1979; 120B():153-61. PubMed ID: 517232
[TBL] [Abstract][Full Text] [Related]
56. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.
Schapira M; Scott CF; Colman RW
Biochemistry; 1981 May; 20(10):2738-43. PubMed ID: 6910423
[TBL] [Abstract][Full Text] [Related]
57. Granulocyte elastase cleaves human high molecular weight kininogen and destroys its clot-promoting activity.
Kleniewski J; Donaldson V
J Exp Med; 1988 Jun; 167(6):1895-907. PubMed ID: 3260266
[TBL] [Abstract][Full Text] [Related]
58. Role of HMW kininogen in surface-mediated activation of Factor XII.
Shimada T; Sugo T; Kato H; Iwanaga S
Adv Exp Med Biol; 1983; 156():73-85. PubMed ID: 6134440
[TBL] [Abstract][Full Text] [Related]
59. Purification of single-chain human low-molecular-weight kininogen and demonstration of its cleavage by human urinary kallikrein.
Maier M; Austen KF; Spragg J
Anal Biochem; 1983 Oct; 134(2):336-46. PubMed ID: 6557772
[TBL] [Abstract][Full Text] [Related]
60. Single-step purification of "kallikrein-resistant" kininogen from rat plasma using monoclonal-antibody immunoaffinity chromatography.
Bedi GS; Back N
Prep Biochem; 1985; 15(3):159-69. PubMed ID: 3851460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
